Navigation Links
US HIFU Announces That 18 Recurrent Prostate Cancer Clinical Trial Sites Are Open For Enrollment
Date:11/9/2010

ana University Medical Center

Indianapolis, Ind.Iowa Clinic

Des Moines, IowaLondon Health Sciences Centre, UWO

London, Ontario, CanadaManitoba Prostate Centre

Winnipeg, Manitoba, CanadaMetropolitan Urology

Jeffersonville, Ind.New York University School of Medicine

New York, N.Y.Specialists in Urology

Naples, Fla.Tulane University School of Medicine

New Orleans, La.University Hospitals Case Medical Center

Cleveland, OhioUniversity of Illinois

Chicago, Ill.Urologic Consultants of Southeastern Pennsylvania

Bala Cynwyd, Pa. VA Connecticut Healthcare System/Yale University

West Haven, Conn.Walter Reed Army Medical Center

Washington, D.C. A partial list of criteria for inclusion in the recurrent trial, which is now in the pivotal phase, includes:

  • Men with biopsy-confirmed, organ-confined recurrent prostate cancer
  • Ages 40-85
  • Treated with external beam radiation therapy (EBRT) two or more years prior

  • For more information on the STAR trial, including a full list of inclusion criteria, please call (877) 874-4389 or visit www.ushifu.com (click on clinical information) or www.clinicaltrials.gov (search term fsi003).  

    About USHIFU LLCUSHIFU LLC (US HIFU), a privately held healthcare company, is a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies. US HIFU manufactures the Sonablate® 500 medical device and is focused currently on treating primary and recurrent prostate cancer using Sonablate® HIFU. The company is engaged in ongoing research for technological advancements for the Sonablate® system or other ultrasound applications. US HIFU was founded in 2004 and is headquartered in Charlotte, N.C. Additional information can be found at

    SOURCE USHIFU, LLC
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Upsher-Smith Laboratories Announces Initiation of Open-Label Extension Study of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
    2. Arcadia Resources Announces Improved Fiscal 2011 Second Quarter Results
    3. Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib Development Program at 52nd American Society of Hematology Annual Meeting
    4. NxStage Announces Fourth Quarter 2010 Investor Conference Schedule
    5. Intercell AG Announces Q3 2010 Results and Updates on R&D Progress and Management
    6. Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments
    7. Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results
    8. Accuray Announces Results for First Quarter of Fiscal 2011
    9. Mindray Announces Third Quarter 2010 Financial Results
    10. Mindray Medical Announces Participation in Upcoming Investor Conferences
    11. Amicus Therapeutics Announces Third Quarter 2010 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/23/2014)... September 23, 2014 Avillion ... the appointment of Jarrod Longcor as ... is responsible for structuring, negotiating and executing successful ... well as providing management and strategic leadership to ... Executive leadership team. Mr Longcor brings ...
    (Date:9/22/2014)... , September 23, 2014 , ... health authorities, increasing rigor for trial master file (TMF) ... industry,s largest TMF survey to date reveals an increase ... to provide auditors with remote access to their electronic ... owners surveyed in the Veeva 2014 Paperless ...
    (Date:9/22/2014)... Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ... $200 million of its common stock in an underwritten ... Merrill Lynch are acting as joint book-running managers for ... option to purchase additional shares of its common stock. ... offering are being sold by Avanir.  The offering is ...
    Breaking Medicine Technology:Avillion Appoints Jarrod Longcor as Chief Business Officer 2Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 2Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 3Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 4Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 3
    ... March 15 URL Pharma, Inc. today announced the launch of an expanded ... eligible for low-cost Colcrys therapy. Uninsured and Medicare Part D patients with household incomes ... Colcrys PAP. This expanded program is available to patients immediately. , ... ...
    ... , March 15 Watson Pharmaceuticals, Inc. ... subsidiary, Watson Laboratories, Inc. – Florida , has ... (FDA) for its Abbreviated New Drug Application (ANDA) for ... Laboratories International SRL,s Cardizem® LA product.  Watson intends to ...
    Cached Medicine Technology:URL Pharma Expands Colcrys(R) Patient Assistance Program 2URL Pharma Expands Colcrys(R) Patient Assistance Program 3URL Pharma Expands Colcrys(R) Patient Assistance Program 4URL Pharma Expands Colcrys(R) Patient Assistance Program 5URL Pharma Expands Colcrys(R) Patient Assistance Program 6Watson Receives FDA Approval for Generic Cardizem(R) LA 2Watson Receives FDA Approval for Generic Cardizem(R) LA 3
    (Date:9/23/2014)... Royal Sport Ultra Clean 100 is the ... of premium sports nutrition products. Its gluten free formula ... without artificial colors or dyes, fillers, added sugar and ... shelves at select GNC retailers, on GNC.com, and through ... a limited time special on its products. Customers can ...
    (Date:9/23/2014)... ADOMANI, Inc. has announced that ... CEO. He is a 13-year veteran in the school, commercial ... of A-Z Bus Sales of Colton, California. While with A-Z ... their top line revenues, profit and market penetration by double ... diesel to all-electric or plug-in hybrid vehicle conversions. They ...
    (Date:9/23/2014)... 23, 2014 Airbus Helicopters Inc. (AHI) ... honored as the 2014 Vision Zero Aviation Safety ... database, a free flight safety service the company ... Manager - Air Medical Specialist for Airbus Helicopters Inc., ... $10,000 check during the Air Medical Transport Conference Annual ...
    (Date:9/23/2014)... issue of the European Journal of Cancer ... presented during the 1st EORTC Cancer Survivorship Summit held ... targeted therapeutics, and more personalized multimodal treatments has boosted ... a large and rapidly increasing number of cancer survivors. ... with a broad spectrum of late adverse treatment effects ...
    (Date:9/23/2014)... a driving force behind many chronic diseases, especially ... inflammation caused by conditions such as viral hepatitis ... options. Now, scientists at Virginia Commonwealth University Massey ... in preclinical studies that blocking the expression of ... halts the development and progression of liver cancer ...
    Breaking Medicine News(10 mins):Health News:Sports Nutrition Brand, Royal Sport LTD, Introduces 'Clean,' Gluten Free Protein Supplement, Royal Sport Ultra Clean 100™ 2Health News:ADOMANI Announces Jim Reynolds to Take Over as President and CEO 2Health News:Protean wins Airbus Helicopters Vision Zero Aviation Safety Award 2Health News:Protean wins Airbus Helicopters Vision Zero Aviation Safety Award 3Health News:Protean wins Airbus Helicopters Vision Zero Aviation Safety Award 4Health News:Study uncovers genetic driver of inflammation, uses it to prevent and treat liver cancer 2
    ... the major arterial blood vessels. It is one of the ... IL-1 has been linked to atherosclerosis and a clinical trial ... is being studied for its effects on the severe clinical ... a team of researchers led by Gary Owens, at the ...
    ... By Steven Reinberg HealthDay Reporter , MONDAY, ... may see their IQ improve, Norwegian researchers have found. ... earlier studies did not rule out the possibility that people ... education than others, the researchers noted. Now, however, ...
    ... like regular schedules for meal, bath, and bed times ... with oral and tactile sensitivities, such as discomfort at ... rituals could be an early warning sign of adult ... Reuven Dar of Tel Aviv University,s Department of Psychology, ...
    ... Teens are more likely to be obese if they had ... toddlers, according to a new study. The findings echo ... ties with their parents were more likely to be obese ... the latest study, researchers examined U.S. National Institute of Child ...
    ... News) -- Being hospitalized during the holidays can be emotionally ... spirits up, experts say. "While the psychological impact ... be well and home than sick and away," Joshua Klapow, ... (UAB), explained in a university news release. "The ...
    ... A global team of neuroscientists, led by researchers at ... for a brain disorder that may be much more common ... Nature Genetics , the researchers say they ... to development of hereditary diffuse leukoencephalopathy with spheroids ...
    Cached Medicine News:Health News:More Schooling Might Raise IQ 2Health News:More Schooling Might Raise IQ 3Health News:Childhood hypersensitivity linked to OCD 2Health News:Mother-Toddler Bond May Influence Teen Obesity 2Health News:A Visit Can Bring Holiday Cheer to Hospitalized Patients 2Health News:'Rare' brain disorder may be more common than thought, say Mayo Clinic scientists 2Health News:'Rare' brain disorder may be more common than thought, say Mayo Clinic scientists 3
    DS 7600 Central Station...
    ... MedSystem III DLE (Drug List Editor) Multi-Channel ... drug infusion technology. The instrument combines three ... clinical versatility in an unparalleled small size. ... MedSystem III Infusion System simplifies the delivery ...
    ... Freedom Chart Manager provides powerful workflow tools ... management, integrated transcription services, and customized flow ... that eliminates the need for paper charts. ... of a paperless office now and can ...
    ... ChartingPlus proves itself to over 2,000 ... Designed with the user in mind, ChartingPlus ... powerful and dynamic features to improve documentation ... practice. Our medical content is ...
    Medicine Products: